89bio Presents New Analysis of Data from Phase 2 ENTRIGUE
– Post hoc analysis data demonstrated pegozafermin treatment significantly reduced triglycerides and other atherogenic lipids in patients with SHTG...
Source: globenewswire.com
Stay updated with breaking news from Expo Together. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Post hoc analysis data demonstrated pegozafermin treatment significantly reduced triglycerides and other atherogenic lipids in patients with SHTG...